🔎 Trials Near Me

Home › Squamous Cell Carcinoma › New York

Squamous Cell Carcinoma clinical trials in New York

15 studies for Squamous Cell Carcinoma are looking for participants at sites in New York.

Cities in New York

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  • Richmond University Medical Center, Staten Island
  • Montefiore Medical Center, The Bronx
RecruitingPhase 3
Ages 60 and older · All sexes · Updated Sep 25, 2026 · NCT04892173

Intratumoral N17350 in Advanced Solid Tumors

  • Roswell Park Comprehensive Cancer Center, Buffalo
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07339176

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06561685

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

  • Roswell Park Cancer Institute, Buffalo
  • START New York Long Island, Lake Success
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07602842

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • Wilmot Cancer Institute at the University of Rochester Medical Center in New Yor, Rochester
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 2, 2026 · NCT04915183

Two-photon Fluorescence Microscopy of Dermatologic Biopsies

  • Rochester Dermatologic Surgery, Victor
Recruiting
All ages · All sexes · Updated Aug 19, 2026 · NCT07773688

Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies

  • Rochester Dermatologic Surgery, Victor
Recruiting
All ages · All sexes · Updated Aug 19, 2026 · NCT07682831

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT05859074

Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology

  • Memorial Sloan Kettering West Harrison (consent only), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • Memorial Sloan Kettering Nassau (consent only), Uniondale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT02507141

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

  • Bassett Healthcare, Cooperstown
Recruiting
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06615635

Raman Spectroscopy and Skin Cancer

  • Stony Brook Hospital, Stony Brook
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT06384924

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • Northwell Health Cancer Institute, Lake Success
  • Manhattan Eye, Ear & Throat Hospital, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT06064877

Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain

  • NYU College of Dentistry, New York
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT07095608

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

  • Bruce Robinson, MD, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2025 · NCT07010692

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Memorial Sloan Kettering, New York
  • Columbia University Herbert Irving Comprehensive Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 15, 2025 · NCT04429542

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.